Preface

The United States National Cancer Institute Surveillance, Epidemiology and End Results (SEER) Program estimates that there will be 48,960 new cases of pancreatic cancer with 40,560 deaths in 2015. The current issue of Translational Cancer Research presents a number of papers which, while recognizing the poor prognosis associated with this malignancy, identify a number of improvements in the diagnosis and therapy which should, in time, improve patient outcomes.